Jabre Capital Partners’s HUTCHMED HCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-10,000
Closed -$322K 54
2018
Q3
$322K Sell
10,000
-27,058
-73% -$825K 0.11% 113
2018
Q2
$1.12M Sell
37,058
-2,029
-5% -$64.4K 0.08% 88
2018
Q1
$1.16M Buy
39,087
+5,029
+15% +$179K 0.25% 84
2017
Q4
$1.34M Buy
34,058
+15,787
+86% +$504K 0.28% 76
2017
Q3
$498K Buy
+18,271
New +$449K 0.1% 84
2016
Q3
Sell
-100,000
Closed -$1.31M 107
2016
Q2
$1.31M Sell
100,000
-170,000
-63% -$2.25M 0.4% 59
2016
Q1
$3.56M Buy
+270,000
New +$3.61M 0.57% 57

Other funds holding HCM

Jabre Capital Partners's HCM Position: Q4 2018 in Review

Jabre Capital Partners sold out of HUTCHMED (HCM) in Q4 2018, closing a stake of 10,000 shares — an estimated $322K sold.

Jabre Capital Partners first reported a position in HCM in Q1 2016 and held it in 7 quarters. The position peaked at $3.56M in Q1 2016. 79 funds tracked by Wall St. Rank hold HCM as of Q4 2018.

  • Jabre Capital Partners reported no remaining HUTCHMED position as of Q4 2018 after selling out during the quarter.
  • Jabre Capital Partners sold 10,000 HUTCHMED shares in Q4 2018, an estimated $322K.
  • Jabre Capital Partners first reported a position in HUTCHMED in Q1 2016 and held it in 7 quarters.
  • Jabre Capital Partners's HUTCHMED position peaked at $3.56M in Q1 2016.
  • 79 funds tracked by Wall St. Rank held HUTCHMED as of Q4 2018.

Based on Jabre Capital Partners's 13F filing for Q4 2018, filed 14 Feb 2019.